Cha, Eugene K.

Publications

Sort by

Co-Author Network

selected publications

Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 130
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy. World journal of urology. 2018 Academic Article GET IT
Times cited: 12
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World journal of urology. 2018 Academic Article GET IT
Times cited: 21
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 67
Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. Urologic oncology. 2016 Academic Article GET IT
Times cited: 10
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer. Urologic oncology. 2016 Academic Article GET IT
Times cited: 49
Genomic characterization of response to chemoradiation in urothelial bladder cancer. Cancer. 2016 Academic Article GET IT
Times cited: 46
Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes. Urology. 2016 Academic Article GET IT
Times cited: 28
Rationale and Early Experience with Prophylactic Placement of Mesh to Prevent Parastomal Hernia Formation after Ileal Conduit Urinary Diversion and Cystectomy for Bladder Cancer. Current urology reports. 2016 Review GET IT
Times cited: 24
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma. The Journal of urology. 2016 Academic Article GET IT
Times cited: 32
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin. BJU international. 2015 Academic Article GET IT
Times cited: 98
Low yield of surveillance imaging after surgery for T1 kidney cancer. World journal of urology. 2015 Academic Article GET IT
Times cited: 2
Genomic Characterization of Upper Tract Urothelial Carcinoma. European urology. 2015 Academic Article GET IT
Times cited: 165
Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?. The Urologic clinics of North America. 2015 Review GET IT
Times cited: 5
Re: whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. European urology. 2015 Comment GET IT
Times cited: 2
Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer. Urologic oncology. 2015 Review GET IT
Times cited: 26
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. European urology. 2014 Academic Article GET IT
Times cited: 176
Risk factors for the development of parastomal hernia after radical cystectomy. The Journal of urology. 2013 Academic Article GET IT
Times cited: 55
High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urologic oncology. 2013 Academic Article GET IT
Times cited: 51
Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. The Journal of urology. 2013 Academic Article GET IT
Times cited: 20
Nonneoplastic renal cortical scarring at tumor nephrectomy predicts decline in kidney function. Archives of pathology & laboratory medicine. 2013 Academic Article GET IT
Times cited: 40
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling. British journal of cancer. 2012 Academic Article GET IT
Times cited: 28
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer. World journal of urology. 2012 Academic Article GET IT
Times cited: 26
Cost-effective treatment of low-risk carcinoma not invading bladder muscle. BJU international. 2012 Academic Article GET IT
Times cited: 27
Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy. Urologic oncology. 2012 Academic Article GET IT
Times cited: 12
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU international. 2012 Academic Article GET IT
Times cited: 63
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. The Journal of urology. 2012 Academic Article GET IT
Times cited: 86
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. BJU international. 2012 Review GET IT
Times cited: 36
Biomolecular predictors of urothelial cancer behavior and treatment outcomes. Current urology reports. 2012 Review GET IT
Times cited: 47
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. European urology. 2012 Academic Article GET IT
Times cited: 80
Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. European urology. 2012 Letter GET IT
Times cited: 146
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. The Journal of urology. 2011 Academic Article GET IT
Times cited: 37
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy. BJU international. 2011 Academic Article GET IT
Times cited: 15
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. European urology. 2011 Academic Article GET IT
Times cited: 62
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy. World journal of urology. 2011 Academic Article GET IT
Times cited: 24
Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study. European urology. 2011 Academic Article GET IT
Times cited: 38
Immunohistochemical biomarkers for bladder cancer prognosis. International journal of urology : official journal of the Japanese Urological Association. 2011 Academic Article GET IT
Times cited: 57
Stage pT0 after radical cystectomy: are all patients equal?. European urology. 2011 Letter GET IT
Times cited: 5
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World journal of urology. 2011 Academic Article GET IT
Times cited: 48
Tim-2 regulates T helper type 2 responses and autoimmunity. The Journal of experimental medicine. 2005 Academic Article GET IT
Times cited: 111
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nature immunology. 2003 Academic Article GET IT
Times cited: 518
Effects of a participatory ergonomics intervention computer workshop for university students: a pilot intervention to prevent disability in tomorrow's workers. Work (Reading, Mass.). 2002 Academic Article GET IT
Times cited: 39

more ...

less ...

Background

education and training

M.D., Harvard Medical School 2007
A.B., Harvard College 2001

Contact

full name

Eugene K. Cha

primary email

euc9010@nyp.org

VIVO Weill Cornell Medical College

Eugene K. Cha Assistant Professor of Urology

Publications

selected publications

Background

education and training

Contact

full name

primary email